Brief: Zoetis Receives European Commission Marketing Authorization For Lenivia (Izenivetmab) To Reduce Pain Associated With Osteoarthritis (OA) In Dogs
26/11/2025 21:17
Nov 26 (Reuters) - Zoetis Inc ZTS.N: ZOETIS RECEIVES EUROPEAN COMMISSION MARKETING AUTHORIZATION FOR LENIVIA® (IZENIVETMAB) TO REDUCE PAIN ASSOCIATED WITH OSTEOARTHRITIS (OA) IN DOGS Source text: ID:nBw8nv7BLa Further company coverage: ZTS.N ((Reuters.Briefs@thomsonreuters.com;))